Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Numico sale of Unicity final

This article was originally published in The Tan Sheet

Executive Summary

Divestiture of Royal Numico division completed July 17. Paulo Bangerter and Aaron Webber will manage the direct selling business as an entrepreneurial venture. The transaction will result in net cash inflow of approximately $22.6 mil. by Q2 2004, the Dutch company said. Numico signed a letter of intent to sell Unicity to Activated Holdings in March (1"The Tan Sheet" March 10, 2003, p. 3)...

You may also be interested in...



GNC Sales Fall 12% In Q4; Numico Considering “All Options” For Chain

A 17% decline in ephedra revenue in 2002 pulled GNC sales down 6% to $1.57 bil. (€1=$1.09) for the year, parent Royal Numico reported in a March 6 presentation on its financial results

Regulatory Measures Could Mitigate Coronavirus Risks In Europe

As part of its response to the coronavirus outbreak, the European association representing generic and biosimilar drug companies, Medicines for Europe, has set out a series of policy recommendations that it says could help to mitigate the possible risks to medicines supply.

Belgium’s Amophar Acquires Patch Pharma, Launches Pharmacy-Only CBD

Amophar has snapped up Belgian player Patch Pharma and at the same time launched the first pharmacy-only CBD available in the country.

Topics

UsernamePublicRestriction

Register

PS095718

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel